• 1. Guangzhou Aier Eye Hospital Affiliated to Jinan University, Guangzhou 510632, China;
  • 2. Changsha Aier Eye Hospital, Aier Eye Institute, Changsha 410035, China;
  • 3. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to the First Medical University of Shandong Province, Jinan 250021, China;
Tang Shibo, Email: tangshibo@vip.163.com
Export PDF Favorites Scan Get Citation

Due to the high incidence and the earlier onset age, high myopia has become an important public health problem in China. Posterior scleral reinforcement surgery has been developed for over 60 years in order to control the rapid progression and complications of high myopia. By suturing a certain size of material on the surface of the posterior eyeball, thickness and elasticity modulus of the local sclera significantly increase. As the result, the rapid growth of the axial length and the chorioretinopathy could be alleviated. At present, controversies about its clinical efficacy and safety still exist, so posterior scleral reinforcement surgery has not been widely carried out all over the world. An in-depth analysis of the mechanism, surgical manipulations and materials, the clinical application status of posterior scleral reinforcement surgery on control of high myopia can provide a basis for further standardized application of this surgery